Gregory L Conn's most recent trade in PDS Biotechnology Corporation was a trade of 46,648 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 28, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PDS Biotechnology Corporation | Gregory L. Conn | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 46,648 | 46,648 | - | - | Employee Stock Option (Right to Buy) | |
| PDS Biotechnology Corporation | Gregory L. Conn | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 40,000 | 40,000 | - | - | Employee Stock Option (Right to Buy) | |
| PDS Biotechnology Corporation | Gregory L. Conn | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 137,200 | 137,200 | - | - | Employee Stock Option (Right to Buy) | |
| PDS Biotechnology Corporation | Gregory L. Conn | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 112,100 | 112,100 | - | - | Employee Stock Option (Right to Buy) |